about
Lighting up multiprotein complexes: lessons from GPCR oligomerizationMolecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R.Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer framework.Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain.G protein-coupled receptor oligomerization and brain integration: focus on adenosinergic transmission.Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulatorThe Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain.Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice.Predicting the antinociceptive efficacy of σ(1) receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor.Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator.G protein-coupled receptor oligomerization for what?Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunitsCaffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD)Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cystsFunctional coupling of GABAA/B receptors and the channel TRPV4 mediates rapid progesterone signaling in the oviductAdenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated EffectsRevealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based AssayL-Serine dietary supplementation is associated with clinical improvement of loss-of-function GRIN2B-related pediatric encephalopathy
P50
Q34730200-E95752F0-BAF2-4F43-9AB2-2F7589D8EA78Q36344943-11D2DEE6-4B3D-468C-B372-391B0501A83BQ36994873-9F17931E-09EA-44FE-A2B8-A88701F70226Q37719729-FAE58069-B63A-4ED3-ADDB-073CB842A1C0Q37840691-4E6E769A-D3E2-4735-AA9A-EC7431A6EE0FQ38009142-FCBC2AD5-BF4B-4FAA-9512-79FEE80C89A9Q38843887-6BC5EDF3-372D-4E52-B10C-75CBE49A1807Q39196741-9D34273E-1D51-49EC-AA4B-2B0B1DB17F96Q43077471-E06CF683-B7D1-40E6-A5A3-3CF3F6F00DA9Q45750770-8F3AF36E-8A9C-40A6-9148-2469B11B1AE5Q48289999-CF63DF05-44F4-4C36-AFFA-CD4ADB35B830Q57781319-08624C39-F8CA-4A78-B00D-257741D8D6B3Q60049914-7D90EE3B-CD19-4F16-9952-73D99C23174BQ83505538-740E405A-466E-4209-ADE5-A413C037C9E8Q84226993-3DCBDC60-D2EA-4FFE-971F-5580BB2F4E3EQ90946801-0C50015A-65FD-45FC-A02E-C96F3B6A3ECFQ92048355-E079F0DA-C12A-453A-9B11-F8C2BCDA9990Q92150656-290DF430-ECDE-4961-9E96-9CAAB57640DAQ92859996-6FE58DBD-461D-49FD-B933-A093B7664DD7
P50
description
investigador
@es
researcher
@en
name
Víctor Fernández-Dueñas
@en
type
label
Víctor Fernández-Dueñas
@en
prefLabel
Víctor Fernández-Dueñas
@en
P31
P496
0000-0001-7834-2965